Statin Therapy

Statin use did not appear associated with suicidality, anxiety disorders or seizures, according to results of a total-population cohort study published in The Lancet Psychiatry.

Alerting cardiologists with active or passive prompts within electronic health records regarding statin therapy in eligible patients with atherosclerotic CVD did not significantly change prescribing rates, researchers found.

Management of lipids and residual cardiovascular risk has been a growing concern in endocrinology, and new data in this area are encouraging.

Residents of Denmark with diabetes and no prior CVD experienced a 61% risk reduction for MI and a 41% for death from 1996 to 2011, according to data presented at the virtual European Society of Cardiology Congress.

A new paper has questioned whether the 2018 American College of Cardiology/American Heart Association Guideline on the Management of Blood Cholesterol appropriately identifies younger high-risk patients as candidates for statin therapy.

A dyslipidemia guideline from the Department of Veterans Affairs and Department of Defense provided recommendations on statin dosing, tests for predicting CVD risk, primary and secondary CVD prevention, nutrition and exercise.

The number of adults with severe hypercholesterolemia prescribed general and high-intensity statins in a Kentucky health system falls below recommended guidelines, according to a study published in The American Journal of Cardiology.

Icosapent ethyl as an adjunct to statin therapy significantly reduced multiple plaque components, including low-attenuation plaque, at 18 months, compared with placebo, according to final results of the EVAPORATE trial.

The 2018 American College of Cardiology/American Heart Association Guideline on the Management of Blood Cholesterol does not flag most younger patients with premature MI as candidates for statin therapy before their event, researchers found.

Healio and Cardiology Today have compiled a list of the most-read articles of July 2020.